This effect of triple therapy was attributed to an increase in tumour cell death and killing of putative breast cancer stem cells[39], which may have been aided by EGFR-mediated inhibition of DNA DSB repair, particularly in PARPi-sensitised breast cancer cells. The gene discussed is EGFR; the disease is breast carcinoma.